Day and night production without stopping! Beijing Food and Drug Administration stationed in 11 anti-epidemic drug companies

As the country enters a new period of home-based epidemic prevention and control, the market demand for new coronavirus prevention and control drugs has further increased. For this reason, Beijing pharmaceutical companies have stepped up production to ensure supply. At present, the Municipal Food and Drug Administration has sent 12 staff members to 11 epidemic prevention and control drug manufacturers to do their best to ensure the supply of epidemic prevention and control drugs. According to the work requirements of the municipal government, the Municipal Food and Drug Administration will send personnel to the drug production enterprises for epidemic prevention and control before 24:00 on December 10. The channel is smooth. | Related reading (Beijing Daily)

Kessy Shan

The recent trend of pharmaceutical stocks is very strong. For example, Yiling Pharmaceutical, which produces anti-new crown virus magic medicine, has seen its stock price soar by 50% within one month from November 11, when the “twenty measures” of the epidemic were released. However, Guizhou Bailing’s exclusive Miao medicine “Ke Su Ting Syrup” and its exclusive product specification “Xiao’er Chaigui Antipyretic Granules” were selected into the “Guidelines for Home Medicine Intervention of New Coronavirus Infected Patients”. Since December 7, there have been two Daily limit.

The infection in Beijing these days should be very serious. Many people have been exposed to the sun in Moments and WeChat groups, but the course of the disease is not long, and the time to really need medication may be even shorter. People may only need to take “fever-reducing medicines” for less than three days, and these medicines are common medicines, and there are many manufacturers, so there is no need to stock up on a lot of medicines, enough for one-time use Yes, I believe this peak wave of medication will soon recede.

This article is reproduced from: https://www.fortunechina.com/jingxuan/25209.htm
This site is only for collection, and the copyright belongs to the original author.